Johnson & Johnson Vision has announced the launch of Acuvue Oasys Max 1, a new contact lens designed to provide wearers with enhanced comfort and visual performance. 

Acuvue Oasys Max 1 is the latest addition to Johnson & Johnson’s Acuvue line of contact lenses, which includes popular products such as Acuvue Oasys, Acuvue Vita, and Acuvue Define. 

The new lens features a thinner design that allows for more oxygen to reach the eye, reducing the risk of eye fatigue and irritation. It also incorporates HydraLuxe technology, which helps to maintain a stable tear film and prevent dryness. 

In addition to its comfort benefits, Acuvue Oasys Max 1 is also designed to provide excellent visual acuity, with a high-definition optics design that enhances contrast and reduces glare. 

According to Johnson & Johnson, the new lens has been well-received by wearers during clinical trials, with 89% reporting that they preferred Acuvue Oasys Max 1 over their previous contact lenses. 

Commenting on the launch, Sheetal Patel, Johnson & Johnson Vision’s Director of Professional Education & Development, said: “We’re excited to bring Acuvue Oasys Max 1 to the market and provide wearers with a new option for enhanced comfort and visual performance. The lens is the result of years of research and development, and we believe it represents a significant step forward in contact lens technology.” 

Acuvue Oasys Max 1 is available now in the United States and is expected to launch in other markets around the world in the coming months.